NLRP3 and cardiac hypertrophy: Hypericin (31), a major active constituent of Hypericum perforatum, has been shown to upregulate autophagy after myocardial infarction, thereby inhibiting the NLRP3 inflammasome pathway, alleviating myocardial hypertrophy, and reducing fibrinogen deposition, ultimately exerting cardioprotective effects.